The Lee Kong Chian School of Medicine (LKCMedicine) trains doctors who put patients at the centre of their exemplary care. The School, which offers both undergraduate and graduate programmes, is named after local philanthropist Tan Sri Dato Lee Kong Chian. Established in 2010 by Nanyang Technological University, Singapore, in partnership with Imperial College London, LKCMedicine aims to be a model for innovative medical education and a centre for transformative research. The School’s primary clinical partner is the National Healthcare Group, a leader in public healthcare recognised for the quality of its medical expertise, facilities and teaching. The School is transitioning to an NTU medical school ahead of the 2028 successful conclusion of the NTU-Imperial partnership to set up a Joint Medical School. In August 2024, we welcomed our first intake of the NTU MBBS programme, that has been recently enhanced to include themes like precision medicine and Artificial Intelligence (AI) in healthcare, with an expanded scope in the medical humanities. Graduates from the five-year undergraduate medical degree programme will have a strong understanding of the scientific basis of medicine, with an emphasis on technology, data science and the humanities.
The Lee Kong Chian School of Medicine’s Office of Innovation and Enterprise (LKCMedicine OIE), established in June 2022, catalyses impactful healthcare innovation across the School. Under the new Vice Dean (Innovation and Enterprise), appointed on 1 April 2025, OIE is scaling a pipeline of multi-year activities, domain-themed conferences, structured innovation clinics, rapid proof-of-concept accelerators, and partner-readiness/IP packaging, to increase LKCMedicine’s visibility and translate research into real-world impact. You will work within LKCMedicine OIE (supported by a junior team member), a lean, agile team that partners across the School, with other universities/hospitals, and with industry, and will report to the Vice Dean (Innovation and Enterprise). The Manager will be involved in building commercializable technology portfolio, building industry outreach, collaborations and other commercial opportunities, and facilitating innovation and entrepreneurial activities in LKCMedicine. The post offers considerable flexibility to help shape forward strategies and priorities as the office grows.
Responsibilities
Drive and manage industry partnerships by identifying commercial needs and aligning them with LKCMedicine’s commercialisation strategy and technology portfolio.
Proactively build and sustain relationships with industry partners across biotech, pharma, medtech, consumer health and adjacent sectors to drive collaboration and commercial opportunities.
Facilitate and oversee industry collaboration agreements by aligning stakeholder expectations and ensuring effective execution and outcomes.
Strengthen engagement with regional and international industry partners, particularly in Asia, and support emerging thematic areas such as AI in Medicine.
Drive industry outreach initiatives, including joint conferences, events and engagement activities, in collaboration with internal stakeholders.
Build and strengthen a commercialisable technology portfolio by organising Innovation Clinics and supporting researchers in securing translational grants and developing viable pipelines.
Serve as the key liaison with NTUitive on technology disclosures, patent filings, IP licensing and commercialisation processes.
Enable innovation and entrepreneurship by supporting spin‑out formation, connecting researchers with mentors and ecosystem partners, and fostering a strong innovation and entrepreneurial culture within LKCMedicine.
Requirements
Degree / Postgraduate degree in life sciences, biomedical sciences or biomedical engineering
At least five (5) years of relevant working experience involving technology development and commercialization, industry collaborations.
Good working knowledge in healthcare and biomedical industry collaborations, building commercializable project pipeline, spin-off companies. Some understanding of technology transfer, IP and commercialization.
Demonstrable track record on execution of successful industry collaborations and successful commercialisation of biomedical/ life-sciences, technology or medical/clinical technologies.
Familiarity with drug discovery/therapeutics and if possible medical device development life cycle.
Effective working networks, local and foreign, with relevant government agencies, ecosystem players, industry and venture capital.
Proactive, curious, fast learner; strong visual storyteller and strategic thinker; collaborative team player who thrives in a lean environment; high integrity and respect for confidentiality; adaptable to shifting priorities.
This is a 3 years contract appointment. We regret to inform that only shortlisted candidates will be notified.
Hiring Institution: LKC